Feb. 14, Toronto, Ont. – Theralase Technologies Inc. has announced the appointment of Dr. Arkady Mandel as Chief Scientific Officer.
Arkady Mandel, M.D., Ph.D., DSc., earned his designation as a medical doctor from the Moscow State Medical University in 1978. His medical residency included internships in dermatology, infectious diseases, urology and venereal diseases at the Central Research Institute of Dermatology and Venerology in 1980, followed by a Ph.D. from the same institution in 1982.
In recognition of his scientific knowledge, original research, publications and extensive contributions to the field of clinical medicine, Dr. Mandel was then awarded the highest academic research degree in science, that of a Doctor of Science. Dr. Mandel's Doctor of Science accreditation majored in biochemistry, microbiology, immunology, biophysics, and photobiology, and was awarded jointly from the Academy of Sciences and the U.S.S.R. Ministry of Public Health in 1989.
Dr. Mandel is one of the key founders of the therapeutic use of lasers in dermatology and other areas of clinical medicine, as well as the originator and developer of phototherapy methods that offer numerous benefits to patients throughout the world.
Roger Dumoulin-White, President and CEO of Theralase Inc. stated that, "We are extremely fortunate to attract an accredited researcher of such a high calibre as Arkady. With over 100 original papers and scientific monographs to his name, combined with over 200 international patents attributed to his research, Dr. Mandel is not only an esteemed medical professional and an internationally respected scientist, but also an experienced executive manager of research and development teams dedicated to the field of biotechnology and drug development.
We look forward to working with Arkady to lead the research and development of our core technologies through to commercialization; specifically, our patented photo dynamic technology platform for the treatment of cancer and eradication of bacteria and viruses, as well as our patented super-pulsed biofeedback laser technology used for the treatment of inflammation and pain in numerous medical conditions."
For more information visit the corporate or regulatory website at www.theralase.com
Theralase appoints new CSO
What's the deal with HST?As of March 1st, P.E.I. became the fifth province in…
Safe space: Massage therapy for children with Autism Spectrum DisorderAccording to the Public Health Agency of Canada, one in…
PODCAST Episode 3: Patient safety and adverse eventsDonelda Gowan maintains adverse events are common with massage therapy…
Groin and hips of hockey players examined in five-second testFive seconds is enough to assess the status of a…
MTAM Annual Conference
May 3-5, 2019
Remedial Massage Therapists Association AGM and Conference
September 13, 2019